Valbiotis SAS Cash Flow Conversion Efficiency

Latest as of December 2025: -0.592x

Valbiotis SAS cash flow conversion efficiency. Based on the latest financial reports, Valbiotis SAS (ALVAL) has a cash flow conversion efficiency ratio of -0.592x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.12 Million ≈ $-4.82 Million USD) by net assets (€6.96 Million ≈ $8.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Valbiotis SAS (2015–2025)

Cash flow conversion efficiency of Valbiotis SAS from 2015 to 2025. This chart illustrates how Valbiotis SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALVAL stock price for real-time trading data and today's change.

Valbiotis SAS Cash Flow Conversion Ratio Explained

Valbiotis SAS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Valbiotis SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Valbiotis SAS ranked by their cash flow conversion efficiency. Also see ALVAL stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Cue Biopharma NASDAQ:CUE	-0.681x
Derwent London PLC LSE:DLN	0.047x
Wir Asia Tbk PT JK:WIRG	0.022x
Ledtech Electronics Corp TW:6164	0.027x
Medicenna Therapeutics Corp TO:MDNA	-0.799x
INSPIREMD 1/18 DL-0001 F:II2	-0.169x
Inmobiliaria Park Rose Iberoamericana SOCIMI SA MC:YPARK	0.003x
Tulikivi Oyj A HE:TULAV	0.045x

Annual Cash Flow Conversion Efficiency for Valbiotis SAS (2015–2025)

The table below shows the annual cash flow conversion efficiency of Valbiotis SAS from 2015 to 2025. Review ALVAL FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€6.96 Million ≈ $8.14 Million	€-8.04 Million ≈ $-9.40 Million	-1.155x	-3.77%
2024-12-31	€10.37 Million ≈ $12.12 Million	€-11.54 Million ≈ $-13.49 Million	-1.113x	-170.73%
2023-12-31	€19.60 Million ≈ $22.91 Million	€-8.06 Million ≈ $-9.42 Million	-0.411x	+40.47%
2022-12-31	€13.31 Million ≈ $15.56 Million	€-9.19 Million ≈ $-10.75 Million	-0.690x	-37.31%
2021-12-31	€14.23 Million ≈ $16.64 Million	€-7.16 Million ≈ $-8.37 Million	-0.503x	-232.07%
2020-12-31	€7.07 Million ≈ $8.27 Million	€2.69 Million ≈ $3.15 Million	0.381x	+163.19%
2019-12-31	€8.21 Million ≈ $9.60 Million	€-4.95 Million ≈ $-5.78 Million	-0.603x	+1.80%
2018-12-31	€7.41 Million ≈ $8.66 Million	€-4.55 Million ≈ $-5.31 Million	-0.614x	-186.99%
2017-12-31	€10.16 Million ≈ $11.88 Million	€-2.17 Million ≈ $-2.54 Million	-0.214x	+90.81%
2016-12-31	€369.00K ≈ $431.40K	€-858.00K ≈ $-1.00 Million	-2.325x	+73.80%
2015-12-31	€80.00K ≈ $93.53K	€-710.00K ≈ $-830.06K	-8.875x	--

About Valbiotis SAS

PA:ALVAL France Packaged Foods

Market Cap

$26.56 Million

€22.71 Million EUR

Market Cap Rank

#23955 Global

#382 in France

Share Price

€0.64

Change (1 day)

+0.00%

52-Week Range

€0.50 - €1.21

All Time High

€10.54